Rare diseases’ collaboration starts with opening its first call
The European Joint Programme (EJP) on rare diseases, has launched a call that marks the start of this network. The aim of the call is to enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project based on complementarities and sharing of expertise, with a clear benefit for patients. Its focus is on collaborative research projects that accelerate diagnosis and/or explore disease progression and mechanisms of rare diseases covering at least one of the following areas:
Research to accelerate diagnosis, wich can include new schemes for finding diagnosis for undiagnosed patients, improved annotation and interpretation of variants and development of diagnostic tests, novel modalities of functional analysis of candidate variants and -omic or multi-omic integrated approaches for discovery of disease causes and mechanisms, or;
Research to explore disease progression and mechanisms, including natural history studies and patient registries, identification of clinical biomarkers, clinical outcome measures and surrogate endpoints and identification of novel pathophysiological pathways in appropriate disease models that effectively mimic the human condition.
There are additional elements to be considered in the application and several approaches and topics are excluded from the scope of this call.
The deadline for submission of pre-proposals is February 15th, 2019. Selected consortia will be invited to submit a full proposal by early May 2019. Indicative deadline for full proposals is June 11, 2019. The Netherlands is participating in this call.
More information on the call can be found on the Rare Disease EJP website.
The European Joint Programme on Rare Diseases (EJP RD) has been established at the start of 2019 to further coordination of the research efforts of European, Associated and non-European countries in the field of rare diseases and implement the objectives of the International Rare Disease Research Consortium (IRDiRC). In this frame they continue the work of the ERA-Net E-Rare, that has successfully implemented ten Joint Transnational Calls for rare disease research projects since 2006.